Does Insurance Cover GLP-1 Treatments Like Foundayo?
Health InsightsThis is one of the most common questions patients ask — and the honest answer is that it depends, and the landscape is changing quickly.
Commercial and employer-sponsored insurance: Coverage for Foundayo will vary by plan. Insurers are generally more willing to cover GLP-1 treatments when prescribed for type 2 diabetes management than for weight loss alone, since weight management has historically been viewed as elective. This perception is shifting as clinical evidence of obesity’s health impacts grows stronger. If your plan does cover Foundayo, you may pay as little as $25 per month using the official Foundayo Savings Card from Eli Lilly.
Medicare: Federal law has historically barred Medicare from covering weight-loss prescription therapies. However, under the Medicare GLP-1 Bridge program announced by CMS in December 2025, eligible Medicare Part D beneficiaries will be able to access Foundayo beginning July 1, 2026, for approximately $50 per month. This bridges to the BALANCE Model, which will expand comprehensive Medicare Part D coverage for obesity treatments from January 1, 2027.
Medicaid: Coverage varies by state. Some state programs cover anti-obesity treatments; others limit or exclude them. Patients should review their individual state plan’s formulary or contact their case manager for current details.
If your insurance does not cover Foundayo, self-pay options from LillyDirect offer a more accessible entry point than most prior GLP-1 treatments. It is also worth asking your doctor to formally document any weight-related comorbidities, as this strengthens the case for insurance approval and prior authorisation requests.
To check whether your specific plan covers Foundayo, review your insurer’s drug formulary — usually available on your plan’s website — or call the member services number on the back of your insurance card.